Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

rTMS for Neuroenhancement

NCT: NCT06214871 · COMPLETED

NCT IDNCT06214871
StatusCOMPLETED
Start Date2023-11-07
Completion2026-06-27
SponsorGerrish MedEsthetics (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this pilot study is to evaluate the effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Sleep Quality, Mood and Memory.

Frequently Asked Questions

What is rTMS for Neuroenhancement?

rTMS for Neuroenhancement is a clinical trial registered under NCT06214871. Current status: COMPLETED.

What is the status of NCT06214871?

The current status of NCT06214871 (rTMS for Neuroenhancement) is: COMPLETED.

When did rTMS for Neuroenhancement start?

rTMS for Neuroenhancement started on 2023-11-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑